Topics

Gliomas | Treatment | Clinical trials | Positron Emission Tomography

Home > Publications > Topics > Gliomas > Treatment > Clinical trials > Positron Emission Tomography

Azam A, Kurbegovic S, Carlsen EA, Andersen TL, Larsen VA, Law I, Skjøth-Rasmussen J, Kjaer A.
Prospective phase II trial of [⁶⁸Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy.
EJNMMI Res. 2024 Oct 29;14(1):100. doi: 10.1186/s13550-024-01164-9. PMID: 39472354. Interventional study. ˍ

Li Y, Wang R, Chen J, Zhu Z, Wang Y, Ma W.
⁶⁸Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study.
EJNMMI Res. 2025 Jan 17;15(1):6. doi: 10.1186/s13550-025-01198-7. PMID: 39821814. Interventional study. ˍ

Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T, Küper AT, Kessler L, Trajkovic-Arsic M, Eckstein M, Gilman E, Nader M, Barbato F, Podleska LE, Hadaschik BA, Hamacher R, Kersting D, von Ostau N, von Tresckow B, Kaelberlah HP, Kesch C, Kuemmel S, Reinacher-Schick A, Schuler M, Siveke JT, Grünwald V, Herrmann K, Fendler WP.
[⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial.
Lancet Oncol. 2025 Aug 4:S1470-2045(25)00299-2. doi: 10.1016/S1470-2045(25)00299-2. PMID: 40774265. Interventional study. ˍ